BRCA2‐associated breast cancers are more likely to be hormone receptor positive (HR+) and have lower tumor grade and mitotic counts compared to BRCA1‐associated breast cancers.4, 6, 8. The gene discussed is BRCA2; the disease is breast carcinoma.